Dr. Somnath Paul | Cancer Immunotherapy | Best Researcher Award
Staff Scientist, Washington University United States
Somnath Paul, Ph.D., is a Staff Scientist in the Department of Pathology and Immunology at Washington University in St. Louis, MO. With a robust academic and research career, he specializes in molecular genetics, epigenetics, and immunology. Over the years, Dr. Paul has contributed significantly to cancer research, developing new strategies for tumor profiling and immunotherapy. He has worked at prestigious institutions like the University of Texas MD Anderson Cancer Center and CSIR-Indian Institute of Chemical Biology, publishing several key research articles.
Profile
🎓 Education
Dr. Paul earned his Ph.D. in Molecular and Human Genetics from Jadavpur University, India (2016), after completing a Master’s in Genetics at the University of Calcutta (2008). He began his academic journey with a Bachelor’s in Physiology from Presidency College, University of Calcutta (2006). His educational foundation laid the groundwork for his research focus on epigenetics, immunology, and cancer biology.
💼 Experience
Dr. Paul’s professional career spans prestigious institutions, including Washington University (2024–Present), University of Texas MD Anderson Cancer Center (2020–2024), and CSIR-Indian Institute of Chemical Biology (2009–2016). His work focuses on immunotherapy, monoclonal antibody production, and the genetic regulation of cancer. He has been a postdoctoral fellow, research scientist, and project assistant, contributing to several groundbreaking research projects in molecular biology, toxicology, and immunology.
🏆 Awards and Honors
Dr. Paul has received notable accolades, such as the prestigious NIH-funded research project on INO80 chromatin remodeling. He was also honored with research excellence awards, including one from GEU, DDN in 2015, and the Early Career Research Award from SERB (2017). Additionally, he received travel grants from DST (2012) and presented a best paper at TriboIndia-2023 Conference.
🔬 Research Focus
Dr. Paul’s research is primarily centered on understanding tumor progression through circulatory tumor cell profiling, tumor remission and relapse monitoring, and novel monoclonal antibody development for immunotherapy. His work includes studying the infection dynamics of herpes viruses, epigenetic mechanisms of cancer, and identifying biomarkers for early disease detection. He aims to enhance therapeutic strategies through innovative platforms and experimental models.
🏆 Conclusion
Dr. Somnath Paul is a strong contender for the Best Researcher Award due to his robust academic and research portfolio, innovative contributions, and extensive publication record. Addressing the identified areas for improvement could further bolster his candidacy for this and similar accolades in the future.
Publication
- Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India
Year: 2012
Authors: N Das, S Paul, D Chatterjee, N Banerjee, NS Majumder, N Sarma, TJ Sau, …
Citations: 150
- Functional compensation of glutathione S-transferase M1 (GSTM1) null by another GST superfamily member, GSTM2
Year: 2013
Authors: P Bhattacharjee, S Paul, M Banerjee, D Patra, P Banerjee, N Ghoshal, …
Citations: 104
- Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex
Year: 2017
Authors: P Sen, J Luo, A Hada, SG Hailu, ML Dechassa, J Persinger, S Brahma, …
Citations: 99
- The Arp8 and Arp4 module acts as a DNA sensor controlling INO80 chromatin remodeling
Year: 2018
Authors: S Brahma, M Ngubo, S Paul, M Udugama, B Bartholomew
Citations: 81
- Arsenic-induced toxicity and carcinogenicity: a two-wave cross-sectional study in arsenicosis individuals in West Bengal, India
Year: 2012
Authors: S Paul, N Das, P Bhattacharjee, M Banerjee, JK Das, N Sarma, A Sarkar, …
Citations: 78
- Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2/Cdk7 complex
Year: 2014
Authors: S Paul, N Banerjee, A Chatterjee, TJ Sau, JK Das, PK Mishra, …
Citations: 65
- Recent advances in arsenic research: significance of differential susceptibility and sustainable strategies for mitigation
Year: 2020
Authors: T Sanyal, P Bhattacharjee, S Paul, P Bhattacherjee
Citations: 62
- Epimutagenesis: A prospective mechanism to remediate arsenic-induced toxicity
Year: 2015
Authors: S Paul, AK Giri
Citations: 52
- Risk of Occupational exposure to Asbestos, Silicon and Arsenic on Pulmonary Disorders: Understanding the Genetic-Epigenetic Interplay and Future Prospects.
Year: 2016
Authors: P Bhattacharjee, S Paul, P Bhattacharjee
Citations: 47
- Epigenetic Modifications of DAPK and p16 Genes Contribute to Arsenic-Induced Skin Lesions and Non-Dermatological Health Effects
Year: 2013
Authors: N Banerjee, S Paul, TJ Sau, JK Das, A Bandyopadhyay, AK Giri
Citations: 44